Charles River highlights increase in demand as tariff uncertainties fadenews2026-02-18T17:33:30+00:00February 18th, 2026|Endpoints News|
Icon’s stock drops 40% after disclosing internal accounting probenews2026-02-12T20:30:10+00:00February 12th, 2026|Endpoints News|
Thermo Fisher to lay off 421 workers as it winds down lab product site in North Carolinanews2026-01-14T15:59:10+00:00January 14th, 2026|Endpoints News|
WuXi AppTec to shutter Texas-based clinical research business news2025-10-29T10:31:41+00:00October 29th, 2025|Endpoints News|
Icon warns of macro environment headwinds as Medpace maintains revenue momentumnews2025-10-23T15:18:35+00:00October 23rd, 2025|Endpoints News|
CROs show signs of recovery but warn the future of R&D funding is uncertainnews2025-07-22T15:33:41+00:00July 22nd, 2025|Endpoints News|
Trump’s ‘Beautiful Bill’ Actually Pushes Manufacturing Abroadnews2025-06-20T13:56:35+00:00June 20th, 2025|The New York Times|
Charles River launches ‘strategic review’ alongside activist investor Elliottnews2025-05-07T15:37:43+00:00May 7th, 2025|Endpoints News|
CROs raise the alarm as clients delay R&D plans over funding, tariff worriesnews2025-05-01T15:02:18+00:00May 1st, 2025|Endpoints News|
West Pharma loses two glucose device clients but is buoyed by its GLP-1 packaging servicesnews2025-02-14T16:15:04+00:00February 14th, 2025|Endpoints News|
